Conjunctive use of platelet glycoprotein IIb/IIIa antagonists and thrombolytic therapy for acute myocardial infarction
Moliterno, D.J.; Topol, E.J.
Thrombosis and Haemostasis 78(1): 214-219
1997
ISSN/ISBN: 0340-6245 PMID: 9198156 Document Number: 481722
Document emailed within 1 workday
Related Documents
Ottani, F.; Bresciani, B.; La Vecchia, L.; Favero, L.; Fontanelli, A.; Galvani, M. 2002: Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 3(5): 544-554Dudek, D.; Bartuś, Sław.; Zmudka, K.; Kuta, M.; Legutko, J.; Wizimirski, M.; Pieniazek, P.; Przewłocki, T.; Gajos, G.; Bryniarski, L.; Dragan, J.; Pasowicz, Mław.; Zorkun, C.; Dubiel, J.S. 2002: Assessment of myocardial reperfusion in patients with acute myocardial infarction treated with combination of fibrinolysis and IIb/IIIa platelet inhibitor Przeglad Lekarski 59(1): 1-6
Gambhir, D.S.; Mukhopadhyay, S. 2000: Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary interventions Indian Heart Journal 52(5): 524-532
Zimarino, M.; De Caterina, R. 2004: Glycoprotein IIb-IIIa antagonists in non-ST elevation acute coronary syndromes and percutaneous interventions: from pharmacology to individual patient's therapy: part 1: the evidence of benefit Journal of Cardiovascular Pharmacology 43(3): 325-332
Mishkel, G.J.; Moore, A.L.; Markwell, S.J.; Ligon, R.W. 2007: Bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in drug-eluting stent implantations in the absence of acute myocardial infarction: clinical and economic results Journal of Invasive Cardiology 19(2): 63-68
Kessler, S.; Kessler, D.; Frishman, W.H. 1999: Antiplatelet therapy: glycoprotein IIb/IIIa receptor antagonists Drugs of Today 35(6): 413-418
Li, W.G.; Chui, Z.C.; Zhoa, Y.J. 1992: Dynamic changes in the platelet granule membrane glycoprotein level in patients with acute myocardial infarction Zhonghua Nei Ke Za Zhi 31(12): 755
Kitagawa, H.; Yamamoto, N.; Yamamoto, K.; Tanoue, K.; Kosaki, G.; Yamazaki, H. 1989: Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells Cancer Research 49(3): 537-541
Ross, A.M. 1989: Thrombolytic therapy for acute myocardial infarction Cardiovascular Clinics 20(1): 209-218
Smucker, D.R.; Burket, M.W. 1988: Thrombolytic therapy in acute myocardial infarction American Family Physician 37(5): 265-274
Iyengar, S.S. 2011: Thrombolytic therapy in acute myocardial infarction Indian Heart Journal 63(1): 45-49
Clem, J.R. 1994: Thrombolytic therapy for acute myocardial infarction South Dakota Journal of Medicine 47(1): 27-28
Franzosi, M.G. 2001: Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 2(9): 1034-1036
Astaf'ev, V.I.; Runovich, A.A.; Grigor'ev, E.G.; Kustov, V.I.; Kuril'skaia, T.E. 1985: Intracoronary thrombolytic therapy of acute myocardial infarction Grudnaia Khirurgiia 5: 58-65
Qian, F.Y. 1987: Advances in thrombolytic therapy in acute myocardial infarction Zhonghua Yi Xue Za Zhi 67(7): 413-416
Kennedy, J.W. 1987: Thrombolytic therapy for acute myocardial infarction: a brief review Heart and Lung: the Journal of Critical Care 16(6 Part 2): 740-745
Quinn, M.J.; Moliterno, D.J. 2002: Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes Minerva Cardioangiologica 50(5): 547-553
Qian, X.X.; Yang, X.S. 1987: Thrombolytic therapy: a new method for the treatment of acute myocardial infarction Zhonghua Nei Ke Za Zhi 26(10): 605-609
Baxley, P.J.; Akin, C.R. 1989: Thrombolytic therapy of acute myocardial infarction in a community hospital Journal of the Arkansas Medical Society 85(8): 334-336
Ogunyankin, K. 1994: Thrombolytic therapy for acute myocardial infarction: GUSTO criticized New England Journal of Medicine 330(7): 505; Author Reply 506